FindTrial
Sign In

S-1 plus oxaliplatin

DRUG5 trials

Sponsors

Fudan University, Xijing Hospital, Sun Yat-sen University, Yonsei University, Aiping Zhou

Conditions

Advanced Gastric CancerGastric CancerGastric or Gastroesophageal Junction AdenocarcinomaGastrointestinal CancerHER2-positiveImmunotherapyLocally Advanced Solid TumorNasopharyngeal Carcinoma

Phase 2

SOX as Salvage Treatment in Nasopharyngeal Carcinoma
TerminatedNCT01403259
Fudan UniversityNasopharyngeal Carcinoma
Start: 2011-07-31End: 2015-12-31Updated: 2014-08-20
Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer
NCT01608646
Xijing HospitalGastrointestinal Cancer
Start: 2012-03-31End: 2018-08-31Target: 200Updated: 2012-05-31
A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer
TerminatedNCT01946061
Yonsei UniversityAdvanced Gastric Cancer
Start: 2015-05-31End: 2016-03-31Updated: 2016-08-19
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma
NCT05218148
Aiping ZhouGastric or Gastroesophageal Junction Adenocarcinoma, HER2-positive, Immunotherapy +4
Start: 2022-04-01End: 2025-12-01Target: 44Updated: 2022-04-06

Phase 3

Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer
NCT01795027
Sun Yat-sen UniversityGastric Cancer
Start: 2011-09-30End: 2018-06-30Target: 724Updated: 2016-10-25

Related Papers

Adjuvant oxaliplatin with S-1 (SOX) versus S-1 in patients with stage II-III gastric or gastro-oesophageal junction adenocarcinoma (CAPITAL): A randomised, open-label, phase 3 trial.
Journal of Clinical Oncology2026-01-10